Swiss drugmaker Novartis said on Tuesday it had submitted its meningitis B vaccine Bexsero for adolescents and young people to the U.S. Food and Drug Administration (FDA) for marketing approval. http://feeds.foxnews.com/~r/foxnews/health/~3/cQA55GTkdAo/
Read More
No comments:
Post a Comment